Erasca, INC. (ERAS) — SEC Filings

Overview

Erasca, INC. (ERAS) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Apr 21, 2026: Erasca, Inc. filed an 8-K on April 21, 2026, to report other events. The filing does not contain specific financial figures or material events beyond the routine reporting of an 8-K.

Sentiment Summary

Across 33 filings, the sentiment breakdown is: 31 neutral, 2 mixed. The dominant filing sentiment for Erasca, INC. is neutral.

Filing Type Overview

Erasca, INC. (ERAS) has filed 1 4, 1 144, 9 8-K, 6 10-Q, 2 DEF 14A, 2 10-K, 4 SC 13G/A, 7 SC 13G, 1 SC 13D/A with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (33)

• Erasca, Inc. Files 8-K — 8-K · Apr 21, 2026 Risk: low
  Erasca, Inc. filed an 8-K on April 21, 2026, to report other events. The filing does not contain specific financial figures or material events beyond the routin
• Alphatec Holdings Insider Reports Ownership Change — 4 · Apr 3, 2026 Risk: low
  On April 1, 2026, Garner Ebun, a reporting person for Alphatec Holdings, Inc., reported a change in beneficial ownership of securities. The filing is a Form 4,
• 144 Filing — 144 · Apr 1, 2026
• Erasca Narrows Q3 Loss, R&D Spend Declines Amid Cash Burn — 10-Q · Nov 12, 2025 Risk: high
  Erasca, Inc. reported a net loss of $30.6 million for the three months ended September 30, 2025, a slight improvement from the $31.2 million net loss in the sam
• Erasca Narrows Q2 Loss by 46% Amid R&D Cost Cuts — 10-Q · Aug 12, 2025 Risk: high
  Erasca, Inc. reported a net loss of $33.876 million for the three months ended June 30, 2025, a significant improvement from the $63.201 million net loss in the
• Erasca, Inc. Files 8-K on Shareholder Vote Matters — 8-K · Jun 26, 2025 Risk: low
  On June 24, 2025, Erasca, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing, made on June 26, 2025, per
• Erasca, Inc. Q1 2025 10-Q: New License Agreements — 10-Q · May 13, 2025 Risk: medium
  Erasca, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial results and provided updates on its business activities. Ke
• Erasca Inc. Files 2025 Proxy Statement — DEF 14A · Apr 29, 2025 Risk: low
  Erasca, Inc. filed its definitive proxy statement (DEF 14A) on April 29, 2025, for its annual meeting on June 24, 2025. The filing details executive compensatio
• 10-K Filing — 10-K · Mar 20, 2025
• Erasca, Inc. Files 8-K Report — 8-K · Jan 13, 2025 Risk: low
  On January 13, 2025, Erasca, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the filing of Financial Statements and Exhibit
• SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• SC 13G Filing — SC 13G · Nov 14, 2024
• Erasca, Inc. Files Q3 2024 10-Q Report — 10-Q · Nov 12, 2024 Risk: medium
  Erasca, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and provided updates on its business activities
• SC 13G Filing — SC 13G · Nov 8, 2024
• SC 13G/A Filing — SC 13G/A · Oct 29, 2024
• SC 13G Filing — SC 13G · Oct 24, 2024
• Erasca, Inc. Files 8-K Report — 8-K · Oct 24, 2024 Risk: low
  On October 24, 2024, Erasca, Inc. filed an 8-K report. The filing indicates no significant new events or material changes requiring immediate disclosure beyond
• Erasca, Inc. Files Q2 2024 10-Q — 10-Q · Aug 12, 2024 Risk: medium
  Erasca, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial position and results of operations. Key financial data point
• Erasca Names Dr. Jonathan Lim CEO — 8-K · Jun 24, 2024 Risk: medium
  On June 18, 2024, Erasca, Inc. announced the appointment of Dr. Jonathan E. Lim as Chief Executive Officer, effective immediately. Dr. Lim, who has served as Ch
• SC 13G Filing — SC 13G · May 31, 2024
• SC 13G Filing — SC 13G · May 29, 2024
• SC 13G Filing — SC 13G · May 28, 2024
• Erasca, Inc. Files 8-K Report — 8-K · May 17, 2024 Risk: low
  On May 16, 2024, Erasca, Inc. filed an 8-K report detailing other events and financial statements. The company, incorporated in Delaware with its principal exec
• Erasca, Inc. Files 8-K for Material Agreement — 8-K · May 16, 2024 Risk: medium
  On May 14, 2024, Erasca, Inc. entered into a material definitive agreement. The company also reported on costs associated with exit or disposal activities and o
• Erasca, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024 Risk: medium
  Erasca, Inc. (ERAS) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Erasca, Inc. filed a 10-Q report for the period ending March 31, 2024. The fili
• Erasca, Inc. Announces 2024 Annual Meeting of Stockholders on June 20 — DEF 14A · Apr 26, 2024 Risk: low
  Erasca, Inc. (ERAS) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Erasca, Inc. will hold its 2024 Annual Meeting of Stockholders on June 20,
• Erasca, Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Mar 28, 2024 Risk: medium
  On March 27, 2024, Erasca, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and provided
• Erasca, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 27, 2024 Risk: medium
  Erasca, Inc. (ERAS) filed a Annual Report (10-K) with the SEC on March 27, 2024. Erasca, Inc. filed its 2023 Form 10-K on March 27, 2024. The company is incorpo
• SC 13G Filing — SC 13G · Feb 14, 2024
• SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Cormorant Amends Erasca 13D Filing; Ownership Update — SC 13D/A · Jan 30, 2024
  Cormorant Asset Management, LP, a significant shareholder in Erasca, Inc., filed an Amendment No. 3 to its Schedule 13D on January 30, 2024. This filing indicat
• Erasca Confirms Emerging Growth Company Status in 8-K Filing — 8-K · Jan 9, 2024
  Erasca, Inc. filed an 8-K on January 9, 2024, indicating it is an "emerging growth company" as defined by the Securities Act of 1933 and the Securities Exchange

Frequently Asked Questions